Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel

ClinicalTrials.gov ID: NCT01306331

Public ClinicalTrials.gov record NCT01306331. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 9:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label, Randomized Study of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a research study of a new experimental vaginal gel that helps in vaginal pH regulation and results in immobilization of spermatozoa by maintaining the normally low vaginal pH, even in the presence of semen. This vaginal gel is called Phexxi™ (previously known as Amphora) and was compared to a commercially available spermicide called Conceptrol®, which contains nonoxynol 9; commonly abbreviated as N-9. Conceptrol® can help prevent pregnancy. This study objective was to determine if this product prevents pregnancy when inserted into the vagina before intercourse.

Study identification

NCT ID
NCT01306331
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Evofem Inc.
Industry
Enrollment
3,389 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 35 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2011 (Type not available)
Primary completion
Jun 2014 (Actual)
Completion
Jun 2014 (Actual)
Last update posted
Jul 12, 2022

2011 – 2014

United States locations

U.S. sites
41
U.S. states
20
U.S. cities
35
Facility City State ZIP Site status
Alabama Clinical Therapeutics, LLC Birmingham Alabama 35235 —
Lynn Institute of the Ozarks Little Rock Arkansas 72205 —
Advanced Clinical Research Institute Anaheim California 92801 —
Anaheim Clinical Trials, LLC Anaheim California 92801 —
California Family Health Council, Inc. Berkeley California 94710 —
California Family and Health Council, Inc., LA Los Angeles California 90010 —
California Family Health Council Los Angeles California 90010 —
Women's Health Care San Diego California 92123 —
Downtown Women's Healthcare Denver Colorado 61820 —
Planned Parenthood of the Rocky Mountains Denver Colorado 80302 —
Stamford Therapeutics Consortium Stamford Connecticut 06095 —
Meridien Research Bradenton Florida 34208 —
Avail Clinical Reseach DeLand Florida 32720 —
Altus Research Lake Worth Florida 33461 —
Miami Research Associates Miami Florida 33143 —
Segal Institute for Clinical Research North Miami Florida 33161 —
Meridien Research St. Petersburg Florida 33709 —
Comprehensive Clinical Trials West Palm Beach Florida 33409 —
Soapstone Center for Clinical Research Decatur Georgia 30034 —
Rosemark WomenCare Specialist Idaho Falls Idaho 83404 —
Heartland Research Associates, LLC Wichita Kansas 67207 —
Johns Hopkins Community Physicians Baltimore Maryland 21211 —
Impact Clinical Trials Las Vegas Nevada 89106 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 —
NYU Medical Center Family Planning New York New York 10016 —
Columbia University Medical Center, Division of Family Planning New York New York 10032 —
Eastern Carolina Women's Center New Bern North Carolina 28562 —
Wake Research Associates Raleigh North Carolina 27612 —
University of Cincinnati Cincinnati Ohio 45267 —
Planned Parenthood of Northeast Ohio Cleveland Ohio 44302 —
Oregon Health Sciences University Portland Oregon 97239 —
University of Pennsylvania Medical Center, Reproductive Research Unit Philadelphia Pennsylvania 19104 —
Philadelphia Clinical Research Philadelphia Pennsylvania 19114 —
Magee-Womens Hospital Pittsburgh Pennsylvania 15213 —
Advanced Research Associates Corpus Christi Texas 78414 —
Practice Research Organization Dallas Texas 75230 —
UT Southwestern Medical Center - Dept. of OB/GYN Dallas Texas 75390 —
TMC Life Research, Inc Houston Texas 77054 —
MacArthur OB/GYN Irving Texas 75062 —
Jean Brown Research Salt Lake City Utah 84124 —
Women's Clinical Research Center Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01306331, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2022 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01306331 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →